tirzepatide and iih Efficacy of Dual GIP/GLP‐1 Receptor Agonist in Patients With Idiopathic Intracranial Hypertension. A Real‐World Propensity Score‐Matched Study - Azzam - 2025 - Endocrinology, Diabetes & Metabolism How Does Tirzepatide Work? |

Its the safety mechanism

While the inherent pharmacokinetic properties of each GLP-1 receptor agonist largely determine elimination time, several patient-specific factors can influence how quickly or slowly these medications clear from the body

Key Takeaway: Tirzepatide has been shown to reduce systolic blood pressure by an average of 7 to 10 mmHg in clinical trials, offering benefits that may rival some traditional blood pressure medications

Research shows that GLP-1 receptors are found in several organs, including the pancreas, heart, and kidneys, which means GLP-1RAs have broad pharmacological effects

No added fat